Dr. Imran A. Khan, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 35
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 504
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
FL license ME106316
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Morton Plant Hospital Clearwater, FL
- Adventhealth North Pinellas Tarpon Springs, FL
- HCA Florida Trinity Hospital Trinity, FL
- Morton Plant North Bay Hospital New Port Richey, FL
Medical groups
- Gulfcoast Pulmonary Associates, PA (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 504
- Services billed
- 1,696
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 411 | 241 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 359 | 130 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 126 | 118 |
| Established patient office or other outpatient visit, 30-39 minutes | 121 | 106 |
| Inhalation treatment for airway obstruction or sputum production | 108 | 105 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 107 | 104 |
| Test to measure largest amount of air breathed in an out | 107 | 104 |
| Test to determine lung volumes using gas dilution or washout | 106 | 103 |
| Test to examine how well the lungs exchange gases | 106 | 103 |
| New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in New Port Richey, FL | 291 |
| Prednisone Other prescribers in New Port Richey, FL | 229 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in New Port Richey, FL | 182 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in New Port Richey, FL | 178 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in New Port Richey, FL | 157 |
| Montelukast Sodium Other prescribers in New Port Richey, FL | 82 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in New Port Richey, FL | 79 |
| Fluticasone Propionate Other prescribers in New Port Richey, FL | 61 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in New Port Richey, FL | 60 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in New Port Richey, FL | 51 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 70 payments worth $1,895 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $296 |
|---|---|
| GlaxoSmithKline, LLC. | $239 |
| Harmony Biosciences LLC | $183 |
| Jazz Pharmaceuticals Inc. | $178 |
| UCB, Inc. | $125 |
| Mallinckrodt Hospital Products Inc. | $115 |
| Insmed, Inc. | $108 |
| Actelion Pharmaceuticals US, Inc. | $99.99 |
| Food and Beverage | $1,760 |
|---|---|
| Education | $135 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. May 20, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $99.99 |
| Insmed, Inc. Dec 10, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
| Insmed, Inc. Sep 24, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.